Functional Analysis of RAD51B and RAD23B SNPs using Circular Chromosome Conformation Capture (4C) in Human Prostate Cell Lines
Poster Nov 02, 2016
C. Cieza-Borrella1, S. Wakerell1 , Q. Karlsson1 , R.A. Eeles1,2, Z. Kote-Jarai1
Prostate Cancer (PrCa) is the most frequently diagnosed cancer among men in developed countries and one of the most heritable solid tumours with 58% of cases estimated to be due to genetic factors. The effectiveness of PSA screening remains controversial and new molecular biomarkers are needed to improve application of treatment.
Findings have led to a mixed model of common and rare variants, with variable effect sizes, to explain PrCa genetic origin. Rare mutations in BRCA2 and BRCA1 give rise to moderately elevated risk, whereas Genome-wide Association Studies (GWAS) have identified over 100 common, low penetrance PrCa susceptibility variants, some near or within RAD51B and RAD23B DNA repair genes 1,2,3
RAD51B is a member of the RAD51 protein family with a relevant role in the homologous recombination repair (HRR) pathway of double stranded DNA breaks. Its overexpression has been found to cause cell cycle delay and apoptosis. Variations in the gene sequence have been associated with breast, ovarian, endometrial, colorectal, head and neck cancer and acute leukaemia. RAD23B is involved in the nucleotide excision repair (NER) system and although its role is still not fully understood, polymorphisms in this gene have been associated with breast cancer susceptibility.
Chromatin is highly organised in topologically associating domains (TADs) comprising 100kb to 1Mb clusters of locally interacting DNA regions. The intra- and inter- dynamic of these domains allows the interaction of different regions involving regulatory elements such as promoters, enhancers and silencers, which consequently leads to the regulation of gene expression and recombination4
Analysis of the Effect of Aggregated β-Amyloid on Cellular Signaling Pathways Critical for Memory in Alzheimer’s DiseasePoster
Here we evaluate the ability to detect changes in phosphorylation levels of ERK and CREB following treatment with Aβ using the SH-SY5Y neuroblastoma cell line.READ MORE
Bioluminescent Kinase Profiling Systems For Characterizing Small Molecule Kinase InhibitorsPoster
In order to profile compounds against a broad panel of kinases, in-house profiling requires rigorous kinase assay development.READ MORE
Characterizing GPCR Activation Using Automated Live Cell ImagingPoster
Here we describe a live cell imaging based approach to detect GPCR activation using the Lionheart™ FX Automated Live Cell Imager and Gen5™ Microplate Reader and Imager Software.READ MORE